rTM (-)
(n=156)
rTM (+)
(n=115)
P-value
Age, years, median (range) 44 (7-77) 47 (16-71) 0.3988
Sex, Male/Female 92/64 69/46 0.8651
Disease
AML 61 41 0.6959
ALL 39 24 0.5290
MDS 21 17 0.7883
Other 35 33 0.3650
Conditioning regimen including TBI
Yes 102 73 0.8823
No 54 42 -
Donor type
Related 52 43 0.7493
Unrelated 104 72 -
Stem Cell Source
Bone marrow 79 60 0.8875
Peripheral blood 39 18 0.1292
Umbilical cord blood 38 37 0.2868
Complication after HSCTC
Known 113 96 0.4440
Yes, aGVHD 75 35 0.0149*
Yes, VOD and/or TMA 40 18 0.0424*
No 22 45 0.0025**
Unknown 43 19 0.0877
Survival at Day 60
Known 108 89 0.5548
Yes 72 61 0.5136
No 36 24 0.7295
Unknown 48 22 0.0940
Quality of life
Known 70 59 0.5336
Good 43 38 0.4756
Not so good 27 21 0.8652
Unknown 41 24 0.4177
rTM: Recombinant Thrombomodulin; AML: Acute Myeloid Leukemia; ALL: Acute Lymphocytic Leukemia; MDS: Myelodysplastic Syndrome; TBI: Total Body Irradiation; HSCT: Hematopoietic Stem Cell Transplantation; aGVHD: Acute Graft-versus-host Disease; VOD: Veno-occlusive Disease; TMA: Thrombotic Microangiopathy.
*: P< 0.05; **: P< 0.01
Table 1: Patient characteristics.